Talsupram

Talsupram is a norepinephrine-dopamine reuptake inhibitor (NDRI) that was never marketed. It is structurally related to other NDRIs such as nomifensine and amfonelic acid.

Pharmacology

Talsupram acts as a norepinephrine-dopamine reuptake inhibitor (NDRI). It inhibits the reuptake of norepinephrine and dopamine, increasing the levels of these neurotransmitters in the brain. This results in increased neuronal activity and stimulation.

Chemistry

Talsupram is structurally related to other NDRIs such as nomifensine and amfonelic acid. It is a synthetic compound and is not found naturally.

History

Talsupram was developed in the 1970s but was never marketed. The reasons for this are not clear, but it may be due to potential side effects or lack of efficacy.

See also

• Norepinephrine-dopamine reuptake inhibitors
• Nomifensine
• Amfonelic acid

Talsupram Resources
Need Help Finding a Doctor? Need help finding a doctor or specialist anywhere in the world? Explore our world directory. WikiMD's DocFinder can assist you in locating millions of physicians.	Medical Knowledge Access the latest research - Most recent articles Ongoing trials.

Translate to: East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski